» Articles » PMID: 34284932

Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper

Abstract

New ultrasound methods that can be used to quantitatively assess liver fat content have recently been developed. These quantitative ultrasound (QUS) methods are based on the analysis of radiofrequency echoes detected by the transducer, allowing calculation of parameters for quantifying the fat in the liver. In this position paper, after a section dedicated to the importance of quantifying liver steatosis in patients with non-alcoholic fatty liver disease and another section dedicated to the assessment of liver fat with magnetic resonance, the current clinical studies performed using QUS are summarized. These new methods include spectral-based techniques and techniques based on envelope statistics. The spectral-based techniques that have been used in clinical studies are those estimating the attenuation coefficient and those estimating the backscatter coefficient. Clinical studies that have used tools based on the envelope statistics of the backscattered ultrasound are those performed by using the acoustic structure quantification or other parameters derived from it, such as the normalized local variance, and that performed by estimating the speed of sound. Experts' opinions are reported.

Citing Articles

Noninvasive Quantification of Hepatic Steatosis Using Ultrasound-Derived Fat Fraction (CHESS2303): A Prospective Multicenter Study.

Huang Y, Li J, Liu C, Song D, Zhu C, Ren Y MedComm (2020). 2025; 6(3):e70123.

PMID: 40027150 PMC: 11868440. DOI: 10.1002/mco2.70123.


Construction of a Compound Model to Enhance the Accuracy of Hepatic Fat Fraction Estimation with Quantitative Ultrasound.

Boglarka Z, Zsombor Z, Ronaszeki A, Egresi A, Stollmayer R, Himsel M Diagnostics (Basel). 2025; 15(2).

PMID: 39857087 PMC: 11763894. DOI: 10.3390/diagnostics15020203.


Abbreviated Multiparametric MR Solution (the "Liver Triple Screen"), the Future of Non-Invasive MR Quantification of Liver Fat, Iron, and Fibrosis.

Low G, Chee R, Wong Y, Tandon P, Manolea F, Locas S Diagnostics (Basel). 2024; 14(21).

PMID: 39518341 PMC: 11545674. DOI: 10.3390/diagnostics14212373.


Evaluation of Liver Parenchyma in Dogs with Hyperlipidemia Using Ultrasound Attenuation Imaging (ATI).

Pelligra T, Citi S, Marchetti V, Habermaass V, Tinalli S, Puccinelli C Vet Sci. 2024; 11(10).

PMID: 39453046 PMC: 11512394. DOI: 10.3390/vetsci11100454.


MASLD: What We Have Learned and Where We Need to Go-A Call to Action.

Hosseini Shabanan S, Martins V, Wolfson T, Weeks J, Ceriani L, Behling C Radiographics. 2024; 44(11):e240048.

PMID: 39418184 PMC: 11580021. DOI: 10.1148/rg.240048.